Results from a 36-Week Open-Label Study of Recombinant Human Growth Hormone and Testosterone in Facioscapulohumeral Muscular Dystrophy (FSHD) (S48.009)

Authors :: Chad Heatwole
Elizabeth Luebbe
Johanna Hamel
Philip Mongiovi
Emma Ciafaloni
Nuran Dilek
William Martens
David Weber
Rashid Hani
Jamie Allen
Claire Smith
Samantha Howell
Spencer Rosero
Katy Eichinger
Linday Baker
Jeanne Dekdebrun
Jim Hilbert
Anika Varma
Michael McDermott
Charles Thornton
Richard Moxley
Source :: Thursday, April 27.
Publication Year :: 2023
Publisher :: Lippincott Williams & Wilkins, 2023.

Full Text Access

Tools